Records containing: Hidradenitis Suppurativa
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2023-03-01An Exploratory, Proof-of-Concept Study of the Effect of Fostamatinib Upon Cutaneous Inflammation in the Setting of Hidradenitis Suppurativa
-
CLINICAL_TRIALS study record update · 2023-01-31An Investigator Initiated, Phase 1b, Randomized, Double-Blind, Placebo-Controlled, Proof-Of-Concept Study to Assess the Safety and Efficacy of a Novel HSP90 Inhibitor (RGRN-305) in the Treatment of Moderate to Severe Hidradenitis Suppurativa
-
CLINICAL_TRIALS study record update · 2023-01-26A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of the Efficacy and Safety of INCB054707 in Participants With Hidradenitis Suppurativa
-
CLINICAL_TRIALS study record update · 2023-01-20Impact of Hidradenitis Suppurativa on Quality of Life Functions: A Cross-Sectional Analysis of 400 Patients
-
CLINICAL_TRIALS study record update · 2022-10-26A 12-Week Double-Blind, Placebo-Controlled Randomized Phase 2 Trial With a 12-Week Open-Label Extension to Determine the Immunomodulatory Activity of PTM-001 in Patients With Hidradenitis Suppurativa
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2022-10-24A Phase 1 Randomized, Placebo-controlled, Single and Multiple Ascending Dose Trial to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Orally Administered KT-474 in Healthy Adult Volunteers and Patients With Atopic Dermatitis (AD) or Hidradenitis Suppurativa (HS)
-
CLINICAL_TRIALS study record update · 2022-10-14Open Label Prospective Trial of Fractional Ablative CO 2 Resurfacing With Laser- Facilitated Steroid Delivery in Patients With Mild to Moderate Hidradenitis Suppurativa.
-
CLINICAL_TRIALS study record update · 2022-09-29Hidradenitis Suppurativa Patients' Experience of Treatment With Adalimumab
-
CLINICAL_TRIALS study record update · 2022-08-11A Phase 2, Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Risankizumab in Adult Subjects With Moderate to Severe Hidradenitis Suppurativa
-
CLINICAL_TRIALS study record update · 2022-08-02Local Control of Hidradenitis Suppurativa After Combination Deroofing and Long-Pulsed 1064-nm Nd:YAG Laser
-
CLINICAL_TRIALS study record update · 2022-07-27The Wound Etiology and Healing Study
-
CLINICAL_TRIALS study record update · 2022-07-27A Small Pilot Study to Develop Biomarkers of Weekly Brodalumab Administration in Hidradenitis Suppurativa Patients
-
CLINICAL_TRIALS study record update · 2022-07-22Randomized Control Trial Comparing Efficacy of Antibiotic Therapy Alone Versus Antibiotic Therapy in Conjunction With Quadruple Pulse Therapy Using NdYag Laser in Treatment of Hidradenitis Suppurativa
-
CLINICAL_TRIALS study record update · 2022-04-06Evaluating the Effect of a Written Action Plan on Comfort and Understanding of Hidradenitis Suppurativa
-
CLINICAL_TRIALS study record update · 2022-03-23Expression of the JAK-STAT Signaling Pathway in Pyoderma Gangrenosum Pathological Biopsy
-
CLINICAL_TRIALS study record update · 2022-03-14A Phase II, Open Label Study of Bermekimab in Patients With Moderate to Severe Hidradenitis Suppurativa
-
CLINICAL_TRIALS study record update · 2022-03-02A Prospective, Randomized, Controlled Clinical Trial Comparing the Efficacy Carbon Dioxide (CO2) Laser Excision Versus Surgical Deroofing in the Treatment of Hidradenitis Suppurativa
-
CLINICAL_TRIALS study record update · 2022-02-24A Single Center, Prospective Clinical Trial of Intravenous Ertapenem in the Treatment of Hurley Stage II or III Hidradenitis Suppurativa
-
CLINICAL_TRIALS study record update · 2022-02-16A Prospective Multi-Center Blinded, Randomized, Controlled Clinical Trial Comparing the Efficacy of Provodine Topical Body Wash Versus 10% Benzoyl Peroxide Topical Body Wash for the Treatment of Hidradenitis Suppurativa
-
CLINICAL_TRIALS study record update · 2022-02-09A Phase 2 Multicenter, Investigator-Blind, Subject-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Pharmacokinetics of Bimekizumab in Subjects With Moderate to Severe Hidradenitis Suppurativa
-
CLINICAL_TRIALS study record update · 2021-10-20A Phase I Study of Low Dose Radiotherapy for Advanced Hidradenitis Suppurativa
-
CLINICAL_TRIALS study record update · 2021-09-28Orismilast for the Treatment of Mild to Severe Hidradenitis Suppurativa (OSIRIS)
-
CLINICAL_TRIALS study record update · 2021-09-08An Open-label, Dose-escalation Study to Evaluate the Use of Allogeneic Micronized Amniotic Membrane Product for the Treatment of Hidradenitis Suppurativa
-
CLINICAL_TRIALS study record update · 2021-08-30Proof of Concept Study on LTX-109 as Treatment for Hidradenitis Suppurativa
-
CLINICAL_TRIALS study record update · 2021-08-04A Phase Ⅱ, Randomized, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of Cannabis Oil for the Treatment of Subjects With Hidradenitis Suppurativa